BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25299091)

  • 1. Value of diffusion weighted imaging in the differential diagnosis of benign and malignant breast lesions at 3.0T MRI.
    Jiang XY; Xie QZ; Cao XS; Gao T; Xing CY; Li XL
    Genet Mol Res; 2014 Sep; 13(3):7773-9. PubMed ID: 25299091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of apparent diffusion coefficient values in the differential diagnosis of breast lesions in diffusion-weighted MRI.
    Şahin C; Arıbal E
    Diagn Interv Radiol; 2013; 19(6):457-62. PubMed ID: 24004972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.
    Cakir O; Arslan A; Inan N; Anık Y; Sarısoy T; Gumustas S; Akansel G
    Eur J Radiol; 2013 Dec; 82(12):e801-6. PubMed ID: 24099642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Diagnosis of Benign and Malignant Breast Tumors Using Apparent Diffusion Coefficient Value Measured Through Diffusion-Weighted Magnetic Resonance Imaging.
    Qu RF; Guo DR; Chang ZX; Meng J; Sun Y; Hao SH; Shi G; Sun J
    J Comput Assist Tomogr; 2015; 39(4):513-22. PubMed ID: 25783797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
    Kim SH; Cha ES; Kim HS; Kang BJ; Choi JJ; Jung JH; Park YG; Suh YJ
    J Magn Reson Imaging; 2009 Sep; 30(3):615-20. PubMed ID: 19711411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI.
    Tan SL; Rahmat K; Rozalli FI; Mohd-Shah MN; Aziz YF; Yip CH; Vijayananthan A; Ng KH
    Clin Radiol; 2014 Jan; 69(1):63-71. PubMed ID: 24156797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast MRI: the usefulness of diffusion-weighted sequences for differentiating between benign and malignant lesions].
    Barceló J; Vilanova JC; Albanell J; Ferrer J; Castañer F; Viejo N; Argelaguet M
    Radiologia; 2009; 51(5):469-76. PubMed ID: 19647840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
    Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation of axillary inflammatory and metastatic lymph nodes with diffusion-weighted imaging in animal modes].
    Bai X; Liao Q; Wang JP; Bai RJ; Sun HR; Yu CS; Zhang YT
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(9):592-5. PubMed ID: 22800945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors.
    Razek AA; Gaballa G; Denewer A; Nada N
    NMR Biomed; 2010 Jul; 23(6):619-23. PubMed ID: 20232453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
    Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
    Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?
    Bogner W; Gruber S; Pinker K; Grabner G; Stadlbauer A; Weber M; Moser E; Helbich TH; Trattnig S
    Radiology; 2009 Nov; 253(2):341-51. PubMed ID: 19703869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative apparent diffusion coefficient: a promising tool to differentiate metastatic from benign lymph nodes in animal models.
    Xing W; Sheng J; Chen J; Tian JM; Bi HL
    Chin Med J (Engl); 2011 Sep; 124(18):2907-10. PubMed ID: 22040501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic efficacy of the diffusion weighted imaging in the characterization of different types of breast lesions.
    Kul S; Eyuboglu I; Cansu A; Alhan E
    J Magn Reson Imaging; 2014 Nov; 40(5):1158-64. PubMed ID: 24923252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MR imaging of the breast: comparison of apparent diffusion coefficient values of normal breast tissue with benign and malignant breast lesions.
    Orguc S; Basara I; Coskun T
    Singapore Med J; 2012 Nov; 53(11):737-43. PubMed ID: 23192501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer.
    Park SO; Kim JK; Kim KA; Park BW; Kim N; Cho G; Choi HJ; Cho KS
    J Magn Reson Imaging; 2009 Feb; 29(2):383-90. PubMed ID: 19161191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
    Liu C; Liang C; Liu Z; Zhang S; Huang B
    Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T.
    Tsushima Y; Takahashi-Taketomi A; Endo K
    J Magn Reson Imaging; 2009 Aug; 30(2):249-55. PubMed ID: 19629992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
    Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
    Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.